ライフサイエンスコーパス: messenger RNA

1 ors encoding small hairpin RNAs against Xbp1 messenger RNA.

2 e isolate cardiomyocyte-specific translating messenger RNA.

3 lly located in the 5' untranslated region of messenger RNA.

4 increased LXR protein without change in LXR messenger RNA.

5 ct the synthesis of the RNA pregenome or HBV messenger RNA.

6 cap structure in the synthesis of functional messenger RNA.

7 ation of lipid-like compounds on delivery of messenger RNA.

8 cleaved at the poly(A) signal to release the messenger RNA.

9 g the stability, splicing and translation of messenger RNA.

10 ling the stability and translation of target messenger RNAs.

11 increases in Tlr4, Nanog, Stat3, and Twist1 messenger RNAs.

12 ith TNF (50 ng/mL, 24 hours), and quantified messenger RNAs.

13 Differences in messenger RNA abundance between sepsis and healthy contr

14 The PBMC HO-1 messenger RNA also increased: HA 2.73-fold versus placeb

15 To address this, we measured messenger RNA alterations in hearts from patients who di

16 Messenger RNA alternative splicing (AS) regulates the ex

17 chemistry and HIF-1alpha/2alpha Western blot/messenger RNA analysis of inflamed and healthy ankles to

18 We detected MAN2A1-FER messenger RNA and fusion protein (114 kD) in the hepatoc

19 ntified brain region-specific levels of Oxtr messenger RNA and oxytocin receptor protein with establi

20 en is a steric block ASO that binds the SMN2 messenger RNA and promotes exon 7 inclusion and thus inc

21 n was significantly silenced at the level of messenger RNA and protein after ischemia-reperfusion in

22 Moreover, both messenger RNA and protein concentrations of the antiapop

23 ile acid composition, energy metabolism, and messenger RNA and protein expression of the genes involv

24 CRC cells robustly upregulated MTSS1 at the messenger RNA and protein level, and the accumulated pro

25 that chronic social defeat stress decreases messenger RNA and protein levels of PPARgamma in adipose

26 irmed when examining CoL1A1 and TIMP1, where messenger RNA and protein levels were significantly high

27 and immunoblot analysis were used to measure messenger RNA and protein levels.

28 PGC-1alpha messenger RNA and protein were examined in NAc after rep

29 Levels of IGF2 messenger RNA and protein were increased >20-fold in 15%

30 d in the pathology of L. pneumophila TNFAIP2 messenger RNA and protein were upregulated in response t

31 to a second maxillary molar induced DC-STAMP messenger RNA and protein, along with elevated tartrate-

32 tion (P < .001) and reduced levels of Npc1l1 messenger RNA and protein, but not other cholesterol tra

33 ids with TNF reduced their expression of DRA messenger RNA and protein.

34 a reduction in the levels of CD47 and PD-L1 messenger RNA and protein.

35 1R receptor binding and lower levels of CB1R messenger RNA and protein.

36 kappaB subunit p65 and reduced levels of DRA messenger RNA and protein.

37 Arc messenger RNA and proteins are rapidly induced in the st

38 creased expression of interleukin receptor 1 messenger RNA and release of macrophage inflammatory pro

39 ing small hairpin RNAs (shRNAs) against Anln messenger RNA and studied liver tumorigenesis after admi

40 Random base-pairing interactions between messenger RNAs and noncoding RNAs can reduce translation

41 the developing embryo is driven by maternal messenger RNAs and proteins that assemble into specializ

42 well as sequence/structural elements within messenger RNAs and that non-AUG translation has a profou

43 Expression of miRNAs, messenger RNAs, and inflammatory markers and their inter

44 ents, such as exosomes enriched in proteins, messenger RNAs, and miRs characteristic of parental stem

45 apable of delivery of multiple DNA plasmids, messenger RNAs, and recombinant proteins is developed to

46 ssociated single nucleotide polymorphisms of messenger RNAs are co-expressed with the corresponding m

47 nsition (MZT), in which maternally deposited messenger RNAs are degraded while zygotic transcription

48 Both FBP1/2 messenger RNAs are highly stable, with FBP2 being more s

49 here is no evidence that reovirus genomic or messenger RNAs are spliced, suggesting that T1L mu2 migh

50 ave also recently been identified in coding (messenger) RNAs as well.

51 ltered dendritic localization of alphaCaMKII messenger RNA, as well as a reporter of alphaCaMKII loca

52 nge-like ethanol drinking alters protein and messenger RNA associated with the VTA-CRF system.

53 ictive strategies based on serum protein and messenger RNA biomarkers can identify a subgroup of chil

54 r for advanced glycation end products (RAGE) messenger RNA, but not toll-like receptor 4 in hippocamp

55 ion codon and the degradation of the mutated messenger RNA by nonsense-mediated messenger RNA decay.

56 Interventions: The study evaluated CRX messenger RNA by quantitative polymerase chain reaction

57 DNAzyme hgd40 inhibited expression of GATA3 messenger RNA by unstimulated and stimulated T cells, an

58 At an expanded messenger RNA channel exit, there is a binding platform

59 given hgd40 had reduced expression of GATA3 messenger RNA, compared with mice given a control DNAzym

60 luding gene expression, which is measured as messenger RNA concentration.

61 tional efficiency, we find a highly enriched messenger RNA consensus sequence, R-motif, consisting of

62 use a pre-mRNA to produce one or more mature messenger RNAs containing the coded information with mul

63 erse mechanisms, including nonsense-mediated messenger RNA decay, endoplasmic reticulum-associated pr

64 e mutated messenger RNA by nonsense-mediated messenger RNA decay.

65 ss gene expression through sequence-specific messenger RNA degradation, translational repression, or

66 expression, whereby specific signals within messenger RNAs direct a proportion of translating riboso

67 trategies: (1) transiently active anti-CD123 messenger RNA-electroporated CART (RNA-CART123); (2) T-c

68 Pseudouridylation of messenger RNA emerges as an abundant modification involv

69 CCS52A2 messenger RNA encoding a nuclear protein that promotes a

70 IBD compared with controls, whereas level of messenger RNA encoding indoleamine 2,3-dioxygenase-1 was

71 d histologic analyses and measured levels of messenger RNAs encoding the sugar transporters SGLT1, GL

72 Levels of messenger RNAs encoding tryptophan 2,3-dioxygenase-2 and

73 increased vascular cell adhesion molecule-1 messenger RNA expression (volume-controlled ventilation,

74 Brain messenger RNA expression and brain expression quantitati

75 We previously demonstrated that ERFE messenger RNA expression and serum protein concentration

76 elevated NLRP3, caspase-1 and interleukin-18 messenger RNA expression and, using a mouse model of CHI

77 dent data set that consisted of clinical and messenger RNA expression data (n = 166).

78 (eQTLs) in whole blood and investigated the messenger RNA expression differences in VTE cases and co

79 ative, the global nature of the decreases in messenger RNA expression for genes involved in cardiac e

80 ion of genomic DNA, and quantitation of Bmp6 messenger RNA expression from isolated liver cell popula

81 om systemic sepsis, in comparison to changed messenger RNA expression in nonfailing and failing human

82 r catalytic activity combined with increased messenger RNA expression led to net enhancement of RhoA

83 nge in serum KLOTHO (r = 0.55, P < 0.01) and messenger RNA expression levels (r = 0.40, P < 0.05).

84 Messenger RNA expression levels for 198 mitochondrially

85 Messenger RNA expression levels of nuclear factor kappa-

86 Messenger RNA expression levels of p38 mitogen activated

87 arameters k1 and k3 were consistent with the messenger RNA expression of GLUT1 and hexokinase-2: cult

88 ctivating ligands on AML cells, DAC enhanced messenger RNA expression of inflammatory cytokines, perf

89 d significantly reduced visceral fat-derived messenger RNA expression of interleukin-6, thrombospondi

90 The messenger RNA expression of placental FA synthase (FAS)

91 compendium to infer regulatory activity from messenger RNA expression or DNA methylation (DNAm) profi

92 Cell subtype prediction using messenger RNA expression patterns indicated that NK-cell

93 ucose positron emission tomography (PET) and messenger RNA expression profile data (n = 26) was obtai

94 , 2017, used DNA and RNA sequencing data and messenger RNA expression results from The Cancer Genome

95 ormed a systematic evaluation of genome-wide messenger RNA expression using liver tissues collected f

96 Auts2 messenger RNA expression was also upregulated postmortem

97 ed with down-regulation of hepatic Ccl2/Ccr2 messenger RNA expression, reduced infiltration of the li

98 t results from a persistent increase in RAGE messenger RNA expression.

99 nflux that was accompanied by increased GCLC messenger RNA expression.

100 this finding did not match the corresponding messenger RNA expression.

101 ols, inversely correlated with BIK and MTP18 messenger RNA expression.

102 psin-like activity of the 26S proteasome and messenger RNA expressions of muscle-specific E3 ligases.

103 cone-rod homeobox (CRX) transcription factor messenger RNA for MD evaluation in metastatic retinoblas

104 RESV reduced expression of messenger RNA for RANKL in animals receiving CSI (P <0.0

105 cient ILC2 progenitors failed to up-regulate messenger RNA for the E protein transcription factor inh

106 Retroviruses transcribe messenger RNA for the overlapping Gag and Gag-Pol polypr

107 Messenger RNAs for nine genes responsible for sarcomere

108 Safe and efficient delivery of messenger RNAs for protein replacement therapies offers

109 Messenger RNA function is controlled by the 3' poly(A) t

110 duced from eukaryotic genes were variants of messenger RNA, functioning as intermediates in gene expr

111 tors-such as DNA methylation, which controls messenger RNA generation-are poorly described.We wanted

112 ith UC expressed higher levels of granzyme A messenger RNA (GZMA mRNA) than CD4(+) alphaE(-) cells (P

113 rowing number of nucleobase modifications in messenger RNA have been revealed through advances in det

114 h salivary oral cancer, protein IL-8 and its messenger RNA (IL-8 mRNA) associated, in undiluted human

115 nges and causes robust upregulation of HMGB1 messenger RNA in enriched hippocampal microglia, an effe

116 The higher expression of orexin messenger RNA in female rats was due to actions of gluco

117 PGC-1alpha ribosome-associated messenger RNA in MSN subtypes was assessed after repeate

118 lymerase chain reaction to measure levels of messenger RNAs in colonic biopsies from 60 patients with

119 ng 3'-untranslated regions of VEGF and CPEB4 messenger RNAs in H5V cells, resulting in deletion of tr

120 ssion of interleukin 1beta and interleukin 6 messenger RNAs in mouse bone marrow-derived macrophages.

121 ession caused a reduced up-regulation of DDR messenger RNAs in regenerating hepatocytes.

122 The expression profile of messenger RNAs in the heart of septic patients reveals s

123 ), viperin, and tripartite-motif 21 (TRIM21) messenger RNA indexes in nasal swabs as potential biomar

124 in synthesis, when the ribosome translates a messenger RNA into a nascent polypeptide.

125 rt that fatty acid binding protein-4 (FABP4) messenger RNA is upregulated in adipocytes and AML when

126 can also be excluded during splicing of pre-messenger RNA, leading to different regulation among iso

127 PPM1F and CAMK2 (CAMKII), we examined blood messenger RNA level of CAMK2G in humans and found it to

128 lysis revealed a significant decrease in the messenger RNA level of early B cell factor 1 (EBF1) and

129 sor" (either EREG or AREG in top tertile for messenger RNA level) or "low expressor" (neither EREG no

130 cancer MDA-MB-231, which has the highest xCT messenger RNA level, had the highest tracer uptake (P =

131 nt, reveal striking changes in QKI-dependent messenger RNA levels and splicing of RNA transcripts.

132 senic trioxide and itraconazole reduced GLI1 messenger RNA levels by 75% from baseline (P < .001).

133 Next, we found that PPM1F messenger RNA levels in human blood were downregulated i

134 Surprisingly, the alterations in messenger RNA levels in septic cardiomyopathy were both

135 tinct from and more profound than changes in messenger RNA levels in the hearts of patients with end-

136 ehaviors that were associated with increased messenger RNA levels of CSF1 in the PFC.

137 erone rescued the anxiety-like phenotype and messenger RNA levels of Ppm1f in amygdala and mPFC in ma

138 The primary outcome was the change in messenger RNA levels of the GLI family zinc finger 1 (GL

139 inventories of transcriptome-wide changes in messenger RNA levels provoked by various types of oxidat

140 Furthermore, HIF-1alpha messenger RNA levels vary significantly within CLL patie

141 A corresponding decrease in NPPA messenger RNA levels was also observed at both time poin

142 Increased CSF1 messenger RNA levels were also detected in the postmorte

143 MicroRNA and messenger RNA levels were determined by quantitative rea

144 togen activated protein kinase phosphatase-1 messenger RNA levels were down-regulated.

145 Hdac4 messenger RNA levels were higher in the amygdala 2 h aft

146 ed with variants of PPARGC1A and protein and messenger RNA levels were measured.

147 Ucp2 knockdown (80% at the protein and messenger RNA levels) reduced by 30% cytokine-induced ap

148 cirrhotic tissue displayed increased TANGO1 messenger RNA levels.

149 rter fragment of JAG1 without affecting Jag1 messenger RNA levels.

150 Messenger RNA localization is important for cell motilit

151 denosine (m(6)Am) modifications (m(6)A/m) of messenger RNA mediate diverse cellular functions.

152 )-methyladenosine RNA (m(6)A) is a prevalent messenger RNA modification in vertebrates.

153 sine (m(6)A) is the most common and abundant messenger RNA modification, modulated by 'writers', 'era

154 d mass spectrometry have revealed widespread messenger RNA modifications and RNA editing, with dramat

155 d eIF4G form eIF4F, which interacts with the messenger RNA (mRNA) 5' cap to promote ribosome recruitm

156 nd blood vitamin D metabolites and placental messenger RNA (mRNA) abundance of vitamin D metabolic pa

157 ost-termination complex (PoTC), comprising a messenger RNA (mRNA) and an uncharged transfer RNA (tRNA

158 ate that FLC tumors (n = 6) exhibit distinct messenger RNA (mRNA) and long intergenic non-coding RNA

159 MATERIALS AND We measured DNA damage, messenger RNA (mRNA) and microRNA (miRNA) expression, an

160 PGE2 significantly increased RANKL messenger RNA (mRNA) and protein in HMOBs in a dose-depe

161 ST18 messenger RNA (mRNA) and protein were detectable neither

162 nd concentrates factors required for histone messenger RNA (mRNA) biosynthesis.

163 itates movement of transfer RNAs (tRNAs) and messenger RNA (mRNA) by one codon.

164 ion of gene expression via nonsense-mediated messenger RNA (mRNA) decay (NMD).

165 Ribosomal RNAs (rRNAs) are main effectors of messenger RNA (mRNA) decoding, peptide-bond formation, a

166 We assessed whether messenger RNA (mRNA) detection would correlate better th

167 Messenger RNA (mRNA) dynamics in single cells are often

168 ript release from the chromatin template and messenger RNA (mRNA) export to the cytoplasm.

169 nt increase in IL-1beta, TNF-alpha, and IL-6 messenger RNA (mRNA) expression and positive staining fo

170 We analyzed messenger RNA (mRNA) expression of candidate immune gene

171 all vessel disease phenotypes, as well as on messenger RNA (mRNA) expression of nearby genes, and on

172 Messenger RNA (mRNA) expression of proinflammatory innat

173 Messenger RNA (mRNA) expression of vascular endothelial

174 e polymerase chain reaction array to analyze messenger RNA (mRNA) expression patterns in rectal mucos

175 This leads to altered platelet messenger RNA (mRNA) expression profiles and mild thromb

176 These regional parameters and messenger RNA (mRNA) expression specific to endothelial

177 t SMAD8, knockdown inhibited hepcidin (HAMP) messenger RNA (mRNA) expression.

178 es not only on RNA transcription but also on messenger RNA (mRNA) fate.

179 The expression of specific messenger RNA (mRNA) for biglycan and decorin was determ

180 se oligonucleotides (ASOs) targeting Angptl3 messenger RNA (mRNA) for effects on plasma lipid levels,

181 actor activity, is downregulated in platelet messenger RNA (mRNA) from subjects with a hyperreactive

182 Messenger RNA (mRNA) has emerged as a versatile and high

183 Though therapeutics based on messenger RNA (mRNA) have broad potential in application

184 We measured levels of CD44v6 messenger RNA (mRNA) in pancreatic cancer tissues from 1

185 d with data on human beta-defensin 3 (hBD-3) messenger RNA (mRNA) in skin while adjusting for transcr

186 Here we define a microRNA (miRNA)-messenger RNA (mRNA) interaction map that facilitates ex

187 The delivery of messenger RNA (mRNA) into B cells can be used to modulat

188 former molecule was recently detected at the messenger RNA (mRNA) level in human periodontitis.

189 ions had reduced MPO protein, but normal MPO messenger RNA (mRNA) levels supporting a posttranscripti

190 N(6)-methyladenosine (m(6)A), which affects messenger RNA (mRNA) localization, stability, translatio

191 Messenger RNA (mRNA) modification provides an additional

192 We hypothesized that spliced viral capsid messenger RNA (mRNA) produced during active replication

193 Messenger RNA (mRNA) represents a promising class of nuc

194 which requires combinations of favorable FIX messenger RNA (mRNA) sequence and protein features.

195 rameshifting (-1PRF) is tightly regulated by messenger RNA (mRNA) sequences and structures in express

196 ied the methods to both microRNA (miRNA) and messenger RNA (mRNA) sequencing datasets from a recombin

197 ns are considered to affect the accurate pre-messenger RNA (mRNA) splicing either by influencing regu

198 or (VWF) gene mutations are thought to alter messenger RNA (mRNA) splicing through disruption of cons

199 irectional transit of the ribosome along the messenger RNA (mRNA) template is a key determinant of th

200 lternative splicing generates a diversity of messenger RNA (mRNA) transcripts from a single mRNA prec

201 bilizes interleukin-2(IL-2), IL-4, and IL-10 messenger RNA (mRNA) transcripts.

202 DNA transcription is functionally coupled to messenger RNA (mRNA) translation in bacteria, but how th

203 Although messenger RNA (mRNA) translation is a fundamental biolog

204 d the ability of BCR stimulation to increase messenger RNA (mRNA) translation, which can promote carc

205 abundant internal modification in eukaryotic messenger RNA (mRNA), and affects almost every stage of

206 tors that assist the ribosome in binding the messenger RNA (mRNA), selecting the start codon, and syn

207 the interaction between microRNA (miRNA) and messenger RNA (mRNA), whose deregulation may be sensitiv

208 known as insulin-like growth factor 2 (IGF2) messenger RNA (mRNA)-binding proteins (IGF2BPs), are hig

209 en to allow the recruitment and migration of messenger RNA (mRNA); however, the precise molecular det

210 ory iron-responsive elements (IRE) on target messenger RNAs (mRNA).

211 quantify female gametocytes (targeting Pfs25 messenger RNA [mRNA]) and male gametocytes (targeting Pf

212 and HPLF were stimulated by IL-1beta for 3 (messenger RNA [mRNA]) or 24 (protein) hours.

213 recruiting ribosomes on mitochondria-encoded messenger RNA (mRNAs) have been identified in higher pla

214 , GW182, and PABPC1, as well as a set of 522 messenger RNAs (mRNAs) and 28 mature microRNAs (miRNAs o

215 P), which inhibits the translation of globin messenger RNAs (mRNAs) and selectively enhances the tran

216 and ribosomal densities and that nearly all messenger RNAs (mRNAs) are engaged in translation.

217 ow that over one-third of zebrafish maternal messenger RNAs (mRNAs) can be N(6)-methyladenosine (m(6)

218 ysis of the translatome, which refers to all messenger RNAs (mRNAs) engaged with ribosomes for protei

219 of the lambda repressor CI and the number of messenger RNAs (mRNAs) from P(RM) in individual Escheric

220 eristics attributed to pseudouridine, making messenger RNAs (mRNAs) highly translatable and non-immun

221 rejection-associated miRNAs and their target messenger RNAs (mRNAs) showed induction of proinflammato

222 ryotes requires generation of protein-coding messenger RNAs (mRNAs) via RNA splicing, whereby the spl

223 Further, we identify hundreds of messenger RNAs (mRNAs) whose translation efficiency is d

224 ale gene expression atlas composed of 62,547 messenger RNAs (mRNAs), 17,862 nonmodified proteins, and

225 een regulatory small RNAs (sRNAs) and target messenger RNAs (mRNAs), leading to alterations of mRNA t

226 can transport luminal components, including messenger RNAs (mRNAs), microRNAs, and enzymes, to the c

227 revalent internal modification in eukaryotic messenger RNAs (mRNAs), plays critical roles in many bio

228 ntinue to synthesize protein using a pool of messenger RNAs (mRNAs), ribosomes, and regulatory small

229 cify post-transcriptional fates of mammalian messenger RNAs (mRNAs), yet knowledge of the underlying

230 slational riboswitches--commonly embedded in messenger RNAs (mRNAs)-regulate gene expression through

231 evels of syndecan 1 (SDC1), SMAD7, and SMAD6 messenger RNAs (mRNAs).

232 seq data when studying microRNAs (miRNAs) or messenger RNAs (mRNAs).

233 the most abundant base modification found in messenger RNAs (mRNAs).

234 s and downregulating partially complementary messenger RNAs (mRNAs).

235 Transfer RNA (tRNA) links messenger RNA nucleotide sequence with amino acid sequen

236 n factor G (EF-G) catalyzed translocation of messenger RNA on the ribosome.

237 al to transfer proteins, lipids, small RNAs, messenger RNAs, or DNA between cells via interstitial fl

238 dling root tips confirmed the capture of pre-messenger RNA (pre-mRNA) and exposed distinctions in div

239 RBM39 associates with precursor messenger RNA (pre-mRNA) splicing factors, and inactivat

240 Newly transcribed eukaryotic precursor messenger RNAs (pre-mRNAs) are processed at their 3' end

241 Introns are removed from eukaryotic messenger RNA precursors by the spliceosome in two trans

242 Nearly all eukaryotic messenger RNA precursors must undergo cleavage and polya

243 NF-kappaB-mediated pro-IL-1beta enhancer and messenger RNA production in LeTx-exposed macrophages.

244 upting genes that must be removed as part of messenger RNA production.

245 ngal viability on the pulmonary microRNA and messenger RNA profiles that regulate murine immune respo

246 Functional genomic messenger RNA profiling was applied to predict target up

247 inoacyl-tRNAs (aa-tRNAs) are selected by the messenger RNA programmed ribosome in ternary complex wit

248 ylori led to an increase in levels of MMP-10 messenger RNA, protein secretion, and activity.

249 Subsequently, mice were sacrificed for messenger RNA, protein, and histological analysis of the

250 Nonsense-mediated decay (NMD) is a messenger RNA quality-control pathway triggered by SMG1-

251 es located in the 5'-untranslated regions of messenger RNA requires the temporal synchronization of R

252 y modulated the highest number of miRNAs and messenger RNAs, respectively, relative to control (filte

253 presence of protein targets associated with messenger RNA ribonucleoprotein (mRNP) complexes includi

254 ther investigation of these genes shows that messenger RNA sequence features are major determinants o

255 wo high-dimensional technologies-single-cell messenger RNA sequencing (scmRNAseq) and cytometry by ti

256 mablast heavy and light chain immunoglobulin messenger RNA sequencing and antibody avidity were evalu

257 d transcriptome analysis of the striatum via messenger RNA sequencing to identify the premorbid trans

258 By messenger RNA sequencing, we uncovered a dramatic differ

259 ed included the expression of olfactomedin-4 messenger RNA, serum protein concentrations, and percent

260 In-depth curation of more than 1800 messenger RNAs shows specific gene expansions that can b

261 f glutamic-oxaloacetic transaminase 2 (GOT2) messenger RNA (Spearman R = 0.42, P = 0.03) was observed

262 ed by ribosome haploinsufficiency, can drive messenger RNA-specific effects on protein expression.

263 sense oligonucleotide drug that modifies pre-messenger RNA splicing of the SMN2 gene and thus promote

264 Increased messenger RNA stability was detected in HEK293 cells, in

265 ing, dendritic spine morphology, protein and messenger RNA stability, and catalytic activity were exa

266 s granules, which are known to accumulate as messenger RNA storage and triage centers during hypoxia.

267 RNAs are co-expressed with the corresponding messenger RNAs, suggesting their potential roles in tran

268 slation to investigate the role of this FMRP messenger RNA target in learning-dependent structural pl

269 A possible AGO8-modulated microRNA-messenger RNA target network was inferred.

270 ough their posttranscriptional regulation of messenger RNA targets.

271 -infected mice with BA had 7-fold more Il17a messenger RNA than control mice (P = .02).

272 o and in vivo SHAPE-MaP for human beta-actin messenger RNA that revealed similar global folds in both

273 eCDS then samples a user-specified number of messenger RNAs that code such peptides; alternatively, R

274 s striking decreases in expression levels of messenger RNAs that encode proteins involved in cardiac

275 Rescue of ribosomes translating on messenger RNAs that lack stop codons is one of the co-tr

276 Gene expression profiling has identified messenger RNAs that lead to transformation, but critical

277 eviously thought to be nuclear, shuttle with messenger RNA to the cytoplasm in pluripotent P19 cells,

278 f the stria terminalis, defeat increased Oxt messenger RNA, total OT neurons, and OT/c-fos colocaliza

279 serglycin, tryptase, and carboxypeptidase A messenger RNA transcripts were detected by quantitative

280 mTOR signaling is required for initiation of messenger RNA translation, we hypothesized that cotarget

281 In cultured primary human hepatocytes, SIRT1 messenger RNA was down-regulated after GCA treatment, po

282 IRF6 messenger RNA was found to be reduced 4.5-, 2.9-, 6.6-,

283 GCB DLBCL cancer samples, expression of IRE1 messenger RNA was inversely correlated with the levels a

284 Expression of iNOS messenger RNA was significantly increased in livers of A

285 rder, and major depressive disorder, and the messenger RNA was subjected to transcriptome profiling b

286 whereas p38 mitogen activated protein kinase messenger RNA was up-regulated.

287 We show here that expression of Dkk2 messenger RNAs was significantly upregulated and expande

288 all interfering RNA designed to target PCSK9 messenger RNA, was found to produce sustained reductions

289 the relative expression levels of four host messenger RNAs, was developed to discriminate critically

290 nduced changes in VTA CRF system protein and messenger RNA were also assessed (n = 58).

291 siRNAs against Anln messenger RNA were conjugated to N-acetylgalactosamine t

292 Levels of GATA3 messenger RNA were higher in colon tissues from patients

293 Levels of ANLN messenger RNA were increased in human HCC tissues compar

294 Transcript analyses found that CA1 messenger RNAs were significantly more abundant than tra

295 rythrocytes, express adult beta-globin (HbA) messenger RNA, which confirms intact transcriptional reg

296 second open reading frame of a polycistronic messenger RNA, which would not be translated in the cyto

297 These include nucleic acid (DNA and messenger RNA), whole-inactivated virus, live-attenuated

298 We quantified Oxt messenger RNA with quantitative polymerase chain reactio

299 These may form multiple messenger RNAs with altered regulatory properties or enc

300 vealed widespread and sparse modification of messenger RNAs with N(6)-methyladenosine (m(6)A), 5-meth